<a target="_blank" href="https://www.buzzsprout.com/twilio/text_messages/1235408/open_sms">Send us a text</a>Room for improvement GenFit Head of Global Diagnostics Suneil Hosmane joins the Surfers in exploring the current strengths and drawbacks of Fatty Liver diagnostics. The conversation considers the needs of drug developers, clinicians and patients, and highlights opportunities for improving diagnostic options.

Send us a text Room for improvement GenFit Head of Global Diagnostics Suneil Hosmane joins the Surfers in exploring the current strengths and drawbacks of Fatty Liver diagnostics. The conversation considers the needs of drug developers, clinicians and patients, and highlights opportunities for improving diagnostic options.

<a href="https://www.buzzsprout.com/twilio/text_messages/1235408/open_sms" rel="noopener noreferrer">Send us a text</a>Room for improvement GenFit Head of Global Diagnostics Suneil Hosmane joins the Surfers in exploring the current strengths and drawbacks of Fatty Liver diagnostics. The conversation considers the needs of drug developers, clinicians and patients, and highlights opportunities for improving diagnostic options.

Diagnosing Diagnostics – Part I - Ep 8

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL

Science

Medicine

Health & Fitness

Natural Sciences

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL

Share Diagnosing Diagnostics – Part I - Ep 8

Sign up to save your podcasts

Diagnosing Diagnostics – Part I - Ep 8

Diagnosing Diagnostics – Part I - Ep 8

More shows like Surfing the MASH Tsunami

Freakonomics Radio

Planet Money

Pivot

Diabetes Core Update

The School of Greatness

The Curbsiders Internal Medicine Podcast

The Daily

Up First from NPR

The Indicator from Planet Money

The Peter Attia Drive

All-In with Chamath, Jason, Sacks & Friedberg

Consider This from NPR

EASL Podcasts

Docs Who Lift

The Headlines